News | February 15, 2022
CDSCO recommends EUA for Corbevax in age group 12-18 years
The recommendation has been sent to the DCGI for approval
The recommendation has been sent to the DCGI for approval
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Key takeaways of Q3FY22 quarter & conference call highlights
It will open new frontier for south-to-south collaboration and innovation transfer
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
On track to complete the BLA submission in the first half of 2022
Subscribe To Our Newsletter & Stay Updated
